申请人:——
公开号:US20030153578A1
公开(公告)日:2003-08-14
The invention provides compounds of Formula (I):
1
wherein: R
1
-R
4
, A, D, and L have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.
本发明提供了式(I)的化合物:1其中:R1-R4、A、D和L具有规范中定义的任何值,它们是CCR-3受体拮抗剂,包含它们的制药组合物,以及用于制备它们的方法和中间体的方法。